Activation of Human Osteoblasts Via Different Bovine Bone Substitute Materials With and Without Injectable Platelet Rich Fibrin

Overview

Journal Front Bioeng Biotechnol

Date 2021 Mar 8

PMID 33681155

Citations 10

Authors

Solomiya Kyyak

Sebastian Blatt

Eik Schiegnitz

Diana Heimes

Henning Staedt

Daniel G E Thiem

Keyvan Sagheb

Bilal Al-Nawas

Peer W Kammerer

Affiliations

Soon will be listed here.

Abstract

Introduction: The aim of the study was to compare the effect of four bovine bone substitute materials (XBSM) with and without injectable platelet-reach fibrin for viability and metabolic activity of human osteoblasts (HOB) as well as expression of alkaline phosphatase (ALP), bone morphogenetic protein 2 (BMP-2), and osteonectin (OCN).

Materials And Methods: Cerabone (CB), Bio-Oss (BO), Creos Xenogain (CX) and MinerOss X (MO) ± i-PRF were incubated with HOB. At day 3, 7, and 10, cell viability and metabolic activity as well as expression of ALP, OCN, and BMP-2, was examined.

Results: For non-i-PRF groups, the highest values concerning viability were seen for CB at all time points. Pre-treatment with i-PRF increased viability in all groups with the highest values for CB-i-PRF after 3 and 7 and for CX-i-PRF after 10 days. For metabolic activity, the highest rate among non-i-PRF groups was seen for MO at day 3 and for CB at day 7 and 10. Here, i-PRF groups showed higher values than non-i-PRF groups (highest values: CB + i-PRF) at all time points. There was no difference in ALP-expression between groups. For OCN expression in non-i-PRF groups, CB showed the highest values after day 3, CX after day 7 and 10. Among i-PRF-groups, the highest values were seen for CX + i-PRF. At day 3, the highest BMP-2 expression was observed for CX. Here, for i-PRF groups, the highest increase was seen for CX + i-PRF at day 3. At day 7 and 10, there was no significant difference among groups.

Conclusion: XBSM sintered under high temperature showed increased HOB viability and metabolic activity through the whole period when compared to XBSM manufactured at lower temperatures. Overall, the combination of XBSM with i-PRF improved all cellular parameters, ALP and BMP-2 expression at earlier stages as well as OCN expression at later stages.

Citing Articles

Biofunctionalization of silk fibroin scaffolds with enamel matrix protein and injectable platelet rich fibrin for soft tissue augmentation: an in-ovo study.

Heimes D, Wiesmann-Imilowski N, Heidebrecht T, Blatt S, Pabst A, Becker P Int J Implant Dent. 2025; 11(1):13.

PMID: 39976848 PMC: 11842663. DOI: 10.1186/s40729-025-00601-1.

Does Injectable Platelet-Rich Fibrin Combined With Autogenous Demineralized Dentine Enhance Alveolar Ridge Preservation? A Randomized Controlled Trial.

Amer O, Shemais N, Fawzy El-Sayed K, Saleh H, Darhous M Clin Oral Implants Res. 2024; 36(2):166-177.

PMID: 39429193 PMC: 11810550. DOI: 10.1111/clr.14372.

A comparative analysis of particulate bovine bone substitutes for oral regeneration: a narrative review.

Pabst A, Becker P, Gotz W, Heimes D, Thiem D, Blatt S Int J Implant Dent. 2024; 10(1):26.

PMID: 38801622 PMC: 11130110. DOI: 10.1186/s40729-024-00544-z.

Platelet-rich fibrin as an autologous biomaterial for bone regeneration: mechanisms, applications, optimization.

Jia K, You J, Zhu Y, Li M, Chen S, Ren S Front Bioeng Biotechnol. 2024; 12:1286035.

PMID: 38689760 PMC: 11058865. DOI: 10.3389/fbioe.2024.1286035.

Platelet-rich fibrin for rehydration and pre-vascularization of an acellular, collagen membrane of porcine origin.

Schroger S, Blatt S, Sagheb K, Al-Nawas B, Kammerer P, Sagheb K Clin Oral Investig. 2024; 28(1):99.

PMID: 38227215 PMC: 10791820. DOI: 10.1007/s00784-023-05485-2.

References

Zhang Y, Tangl S, Huber C, Lin Y, Qiu L, Rausch-Fan X . Effects of Choukroun's platelet-rich fibrin on bone regeneration in combination with deproteinized bovine bone mineral in maxillary sinus augmentation: a histological and histomorphometric study. J Craniomaxillofac Surg. 2011; 40(4):321-8. DOI: 10.1016/j.jcms.2011.04.020. View

El-Ghannam A, Ducheyne P, Risbud M, Adams C, Shapiro I, Castner D . Model surfaces engineered with nanoscale roughness and RGD tripeptides promote osteoblast activity. J Biomed Mater Res A. 2004; 68(4):615-27. DOI: 10.1002/jbm.a.20051. View

Kubler A, Neugebauer J, Oh J, Scheer M, Zoller J . Growth and proliferation of human osteoblasts on different bone graft substitutes: an in vitro study. Implant Dent. 2004; 13(2):171-9. DOI: 10.1097/01.id.0000127522.14067.11. View

El Bagdadi K, Kubesch A, Yu X, Al-Maawi S, Orlowska A, Dias A . Reduction of relative centrifugal forces increases growth factor release within solid platelet-rich-fibrin (PRF)-based matrices: a proof of concept of LSCC (low speed centrifugation concept). Eur J Trauma Emerg Surg. 2017; 45(3):467-479. PMC: 6579868. DOI: 10.1007/s00068-017-0785-7. View

Anselme K . Osteoblast adhesion on biomaterials. Biomaterials. 2000; 21(7):667-81. DOI: 10.1016/s0142-9612(99)00242-2. View

Keselowsky B, Wang L, Schwartz Z, Garcia A, Boyan B . Integrin alpha(5) controls osteoblastic proliferation and differentiation responses to titanium substrates presenting different roughness characteristics in a roughness independent manner. J Biomed Mater Res A. 2006; 80(3):700-10. DOI: 10.1002/jbm.a.30898. View

Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron R . Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Platelets. 2017; 29(1):48-55. DOI: 10.1080/09537104.2017.1293807. View

Wend S, Kubesch A, Orlowska A, Al-Maawi S, Zender N, Dias A . Reduction of the relative centrifugal force influences cell number and growth factor release within injectable PRF-based matrices. J Mater Sci Mater Med. 2017; 28(12):188. DOI: 10.1007/s10856-017-5992-6. View

Dau M, Kammerer P, Henkel K, Gerber T, Frerich B, Gundlach K . Bone formation in mono cortical mandibular critical size defects after augmentation with two synthetic nanostructured and one xenogenous hydroxyapatite bone substitute - in vivo animal study. Clin Oral Implants Res. 2015; 27(5):597-603. DOI: 10.1111/clr.12628. View

10.

Anderson H, Sipe J, Hessle L, Dhanyamraju R, Atti E, Camacho N . Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol. 2004; 164(3):841-7. PMC: 1613274. DOI: 10.1016/s0002-9440(10)63172-0. View

11.

Parisi L, Buser D, Chappuis V, Asparuhova M . Cellular responses to deproteinized bovine bone mineral biofunctionalized with bone-conditioned medium. Clin Oral Investig. 2020; 25(4):2159-2173. PMC: 7966141. DOI: 10.1007/s00784-020-03528-6. View

12.

Miron R, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S . Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry?. Clin Oral Investig. 2017; 21(8):2619-2627. DOI: 10.1007/s00784-017-2063-9. View

13.

Miron R, Zhang Y . Autologous liquid platelet rich fibrin: A novel drug delivery system. Acta Biomater. 2018; 75:35-51. DOI: 10.1016/j.actbio.2018.05.021. View

14.

Ong J, Hoppe C, Cardenas H, Cavin R, Carnes D, Sogal A . Osteoblast precursor cell activity on HA surfaces of different treatments. J Biomed Mater Res. 1998; 39(2):176-83. DOI: 10.1002/(sici)1097-4636(199802)39:2<176::aid-jbm2>3.0.co;2-m. View

15.

Hessle L, Johnson K, Anderson H, Narisawa S, Sali A, Goding J . Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A. 2002; 99(14):9445-9. PMC: 123160. DOI: 10.1073/pnas.142063399. View

16.

Klein M, Kammerer P, Gotz H, Duschner H, Wagner W . Long-term bony integration and resorption kinetics of a xenogeneic bone substitute after sinus floor augmentation: histomorphometric analyses of human biopsy specimens. Int J Periodontics Restorative Dent. 2013; 33(4):e101-10. DOI: 10.11607/prd.1469. View

17.

Ghanaati S, Booms P, Orlowska A, Kubesch A, Lorenz J, Rutkowski J . Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. J Oral Implantol. 2014; 40(6):679-89. DOI: 10.1563/aaid-joi-D-14-00138. View

18.

Trajkovski B, Jaunich M, Muller W, Beuer F, Zafiropoulos G, Houshmand A . Hydrophilicity, Viscoelastic, and Physicochemical Properties Variations in Dental Bone Grafting Substitutes. Materials (Basel). 2018; 11(2). PMC: 5848912. DOI: 10.3390/ma11020215. View

19.

Barbeck M, Udeabor S, Lorenz J, Schlee M, Holthaus M, Raetscho N . High-Temperature Sintering of Xenogeneic Bone Substitutes Leads to Increased Multinucleated Giant Cell Formation: In Vivo and Preliminary Clinical Results. J Oral Implantol. 2014; 41(5):e212-22. DOI: 10.1563/aaid-joi-D-14-00168. View

20.

Liu F, Malaval L, Aubin J . Global amplification polymerase chain reaction reveals novel transitional stages during osteoprogenitor differentiation. J Cell Sci. 2003; 116(Pt 9):1787-96. DOI: 10.1242/jcs.00376. View